OLDAKOWSKI MARK 4

What Happened
Mark Oldakowski, Chief Operating Officer of Bionano Genomics (BNGO), had 27 shares of common stock withheld by the company on June 3, 2026 to satisfy tax withholding obligations related to vested restricted stock units (RSUs). The withheld shares were valued at $1.30 each, totaling $35. This was a tax-withholding disposition (transaction code F), not an open‑market sale.

Key Details

• Transaction date: 2026-06-03
• Transaction type/code: Tax withholding upon RSU settlement (F)
• Shares withheld/disposed: 27 shares at $1.30/share; total value $35
• Origin of award: RSU grant dated June 3, 2024 that vested June 3, 2026 (per footnote)
• Shares issued: 27 shares were not issued to Oldakowski; they were retained by the issuer to cover taxes
• Shares owned after transaction: Not specified in the provided filing excerpt
• Filing timeliness: Report filed on 2026-06-03 (same day as transaction); no late filing indicated

Context
This is a routine tax-withholding event common when RSUs vest. It should not be interpreted as a market sale or a directional bet by the insider. The dollar amount is immaterial ($35), and the transaction reflects fulfillment of tax obligations rather than discretionary selling.